Freenome, Inc. Operating Cash Flow
Freenome, Inc. (FRNM) reported Operating Cash Flow of -$427.66 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-18
- Freenome, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$129.81K.
- Freenome, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$297.85K.
- Freenome, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$312.88K.
- Freenome, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$166.50K.
| Period end | Net Cash Provided by (Used in) Operating Activities 0 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$129.81K derived: S-1 6 month − S-4/A 3 month · filed 2026-08-18 | -$427.66K S-1 · filed 2026-08-18 | -$740.54K derived: sum of 3 quarters · filed 2026-08-18 | -$907.04K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2026-03-31 | -$297.85K S-4/A · filed 2026-06-11 | -$610.73K derived: sum of 2 quarters · filed 2026-08-18 | -$777.23K derived: sum of 3 quarters · filed 2026-08-18 | -$924.76K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-12-31 | -$312.88K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-18 | -$479.38K derived: sum of 2 quarters · filed 2026-08-18 | -$626.91K derived: sum of 3 quarters · filed 2026-08-18 | -$864.65K S-1 · filed 2026-08-18 | |
| 2025-09-30 | -$166.50K derived: 10-Q 9 month − S-1 6 month · filed 2025-11-13 | -$314.03K derived: sum of 2 quarters · filed 2026-08-18 | -$551.77K 10-Q · filed 2025-11-13 | -$631.54K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-06-30 | -$147.53K derived: S-1 6 month − S-4/A 3 month · filed 2026-08-18 | -$385.27K S-1 · filed 2026-08-18 | -$465.04K derived: sum of 3 quarters · filed 2026-08-18 | -$542.57K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-03-31 | -$237.75K S-4/A · filed 2026-06-11 | -$317.52K derived: sum of 2 quarters · filed 2026-08-18 | -$395.04K derived: sum of 3 quarters · filed 2026-08-18 | -$591.37K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2024-12-31 | -$79.77K derived: S-1 9 month − 10-Q 6 month · filed 2026-08-18 | -$157.30K derived: sum of 2 quarters · filed 2026-08-18 | -$353.62K S-1 · filed 2026-08-18 | ||
| 2024-09-30 | -$77.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$273.85K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$196.33K 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |